-
EP4593929
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4593929
| EP4593929 - RISPERIDONE DOSAGE REGIMENS WITH GASTRIC RESIDENCE SYSTEMS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 04.07.2025 Database last updated on 08.04.2026 | |
| Former | The international publication has been made Status updated on 06.04.2024 | Most recent event Tooltip | 30.01.2026 | Change - applicant | published on 04.03.2026 [2026/10] | Applicant(s) | For all designated states Nortiva Bio, Inc. 20 Maguire Road Lexington, Massachusetts 02421 / US | [2026/10] |
| Former [2025/32] | For all designated states Lyndra Therapeutics, Inc. 65 Grove Street, Suite 301 Watertown, Massachusetts 02472 / US | Inventor(s) | 01 /
SCRANTON, Richard Watertown, MA 02472 / US | 02 /
NAGARAJ, Nayana Watertown, MA 02472 / US | 03 /
JIANG, Xuemin Watertown, MA 02472 / US | [2025/32] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2025/32] | Application number, filing date | 23874035.1 | 29.09.2023 | [2025/32] | WO2023US75648 | Priority number, date | US202263377961P | 30.09.2022 Original published format: US 202263377961 P | [2025/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2024073752 | Date: | 04.04.2024 | Language: | EN | [2024/14] | Type: | A2 Application without search report | No.: | EP4593929 | Date: | 06.08.2025 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.04.2024 takes the place of the publication of the European patent application. | [2025/32] | Search report(s) | International search report - published on: | US | 30.05.2024 | Classification | IPC: | A61M31/00, A61K47/34, A61K9/00, A61K9/20, A61K9/70 | [2025/32] | CPC: |
A61K31/519 (EP,IL)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2025/32] | Title | German: | RISPERIDON-DOSIERUNGSSCHEMATA MIT MAGENVERWEILSYSTEMEN | [2025/32] | English: | RISPERIDONE DOSAGE REGIMENS WITH GASTRIC RESIDENCE SYSTEMS | [2025/32] | French: | SCHÉMAS POSOLOGIQUES DE RISPÉRIDONE AVEC SYSTÈMES DE RÉSIDENCE GASTRIQUE | [2025/32] | Entry into regional phase | 16.04.2025 | National basic fee paid | 16.04.2025 | Search fee paid | 16.04.2025 | Designation fee(s) paid | 16.04.2025 | Examination fee paid | Examination procedure | 16.04.2025 | Examination requested [2025/32] | 10.11.2025 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 12.12.2025 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.09.2025 | 03 M06 Fee paid on 12.12.2025 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY] WO2022159529 (LYNDRA THERAPEUTICS INC et al.) [X] 55-60, 62 * para [0004]; [0013]; [0050]-[0054]; [0062]; [0071]; [0095]; [0099]; [0317]; [0350]-[0357] *[Y] 1-8, 17-24, 39-45 | [Y] US2011052700 (HAN CHIEN-HSUAN et al.) [Y] 1-8, 17-24, 39-45 * para [0009]; [0054]; [0172] * | [A] US2019070108 (BELLINGER ANDREW et al.) [A] 1-8, 17-24, 39-45, 55-60,62 * full document * | [X,P] WO2023141524 (LYNDRA THERAPEUTICS INC et al.) [X,P] 1-8, 17-24, 39-45, 55-60,62 * full document * |